羧化不全骨鈣素與冠心病類型及其病變程度的相關(guān)性研究
[Abstract]:Objective: to investigate the relationship between serum carboxylation of incomplete osteocalcin and the type of coronary artery disease and the degree of coronary artery disease, and whether serum carboxylated incomplete osteocalcin level is an independent risk factor for coronary heart disease. Methods: 180 patients undergoing coronary angiography were selected as study objects. Collect patient history data, general data include: age, gender, diabetes history, hypertension history, smoking history, alcohol history. Laboratory data include: serum carboxylation incomplete osteocalcin, blood lipids, blood sugar and so on. Clinical parameters: systolic blood pressure, diastolic blood pressure, coronary angiography and echocardiography. According to the results of coronary angiography, 140 cases in coronary heart disease group and 40 cases in normal control group were divided into two groups. To compare the difference of clinical indexes between the two groups. According to the type of coronary heart disease, coronary heart disease group was divided into three groups: acute myocardial infarction (AMI), unstable angina pectoris (UAP), stable angina pectoris (SAP). At the same time, according to the number of vessel branches, they were divided into two groups: single vessel group and multi-vessel lesion group. The serum carboxylation incomplete osteocalcin levels were compared among each group. To investigate the correlation between serum carboxylated osteocalcin and severity of coronary artery disease according to Gensini score. Multivariate Logistic regression analysis was performed to determine whether serum carboxylation of osteocalcin was an independent risk factor for coronary heart disease (CHD). The result is 1: 1. The level of serum carboxylation incomplete osteocalcin in coronary heart disease group was significantly lower than that in non-coronary heart disease group [(1.02 鹵0.35) ng/ml vs (1.32 鹵0.51) ng/ml], the difference was statistically significant (P0.05) .2. Serum carboxylated osteocalcin levels in SAP group were (1.22 鹵0.38) ng/ml, (1.04 鹵0.23) ng/ml, (0.89 鹵0.21) ng/ml., respectively. Serum carboxylation incomplete osteocalcin levels in the three groups were significantly lower than that in the non-coronary heart disease group (1.32 鹵0.51) ng/ml, difference was statistically significant (P0.05) .3. The serum carboxylation incomplete osteocalcin levels were (1.32 鹵0.51) ng/ml, (1.10 鹵0.36) ng/ml, (0.97 鹵0.34) ng/ml o in normal control group, (1.32 鹵0.51) ng/ml, in single group and (0.97 鹵0.34) ng/ml o in multivessel lesion group. The serum level of osteocalcin in multivessel lesion group was significantly lower than that in single vessel lesion group (P0.05). 4. Serum carboxylation incomplete osteocalcin levels were (0.96 鹵0.32) ng/ml, (1.12 鹵0.34) ng/ml, in Gensini high score group and (0.96 鹵0.32) ng/ml, in Gensini low score group, the difference was statistically significant (P0.05). Multivariate Logistic regression analysis was performed in patients with coronary heart disease. The results showed that the low serum carboxylation incomplete osteocalcin level was an independent risk factor for coronary heart disease. Conclusion 1. The level of serum carboxylation incomplete osteocalcin was closely related to the type of coronary heart disease and the severity of coronary artery disease. Low serum carboxylation incomplete osteocalcin level is an independent risk factor for coronary heart disease and can be used for early detection of clinical coronary heart disease risk population.
【學(xué)位授予單位】:湖南師范大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2016
【分類號】:R541.4
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 郭曉梅;中老年人骨鈣素含量與影響因素分析[J];中國校醫(yī);2001年02期
2 賈建成,石銀華;骨鈣素檢測的臨床應(yīng)用[J];寧夏醫(yī)學(xué)雜志;2002年10期
3 葉凌,李江寧,李聯(lián)欽;骨鈣素在體內(nèi)的表達(dá)[J];國外醫(yī)學(xué).口腔醫(yī)學(xué)分冊;2002年04期
4 方少均,潘光成,俞莉;尿脫氧吡啶啉骨鈣素評價糖尿病骨代謝異常的價值[J];浙江臨床醫(yī)學(xué);2004年08期
5 馬云;羅貴有;王明飛;;深圳地區(qū)2333名健康人骨鈣素水平分析[J];中國臨床保健雜志;2006年02期
6 江莎;侯加法;;骨鈣素臨床應(yīng)用研究進(jìn)展[J];中國骨質(zhì)疏松雜志;2010年05期
7 王計艷;邢學(xué)農(nóng);;骨鈣素對糖、脂代謝影響的研究進(jìn)展[J];國際病理科學(xué)與臨床雜志;2011年01期
8 徐勇;王鋒;;骨鈣素的研究進(jìn)展及其與運(yùn)動的聯(lián)系[J];武漢商業(yè)服務(wù)學(xué)院學(xué)報;2011年06期
9 李美子;宋永坡;;骨鈣素與2型糖尿病及代謝影響的研究進(jìn)展[J];吉林醫(yī)學(xué);2012年14期
10 柴本甫;;骨鈣素[J];國外醫(yī)學(xué).創(chuàng)傷與外科基本問題分冊;1988年01期
相關(guān)會議論文 前10條
1 胡雪琴;糜漫天;;骨鈣素及其表達(dá)調(diào)控[A];中國營養(yǎng)學(xué)會營養(yǎng)科研基金項目論文匯編之一[C];2006年
2 蘭以撒;蔡景英;柳亢中;喻業(yè)安;;肺心病患者骨鈣素放免測定[A];骨質(zhì)疏松研究與防治文集[C];1994年
3 柯耀華;何進(jìn)衛(wèi);傅文貞;章振林;;中國正常人群中骨鈣素水平與糖脂代謝的研究[A];中華醫(yī)學(xué)會第六次全國骨質(zhì)疏松和骨礦鹽疾病學(xué)術(shù)會議暨中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會成立十周年論文匯編[C];2011年
4 柯耀華;何進(jìn)衛(wèi);傅文貞;章振林;;中國正常人群中骨鈣素水平與糖脂代謝的研究[A];中華醫(yī)學(xué)會第三次骨質(zhì)疏松和骨礦鹽疾病中青年學(xué)術(shù)會議論文匯編[C];2011年
5 柯耀華;何進(jìn)衛(wèi);傅文貞;章振林;;中國正常人群中骨鈣素水平與糖脂代謝的研究[A];中華醫(yī)學(xué)會第十次全國內(nèi)分泌學(xué)學(xué)術(shù)會議論文匯編[C];2011年
6 鄭純禮;任莉芬;陳爾秀;;母乳汁內(nèi)骨鈣素等六種生化指標(biāo)的測定[A];第五屆全國優(yōu)生科學(xué)大會論文匯編[C];2000年
7 陳斌;徐又佳;;膜鐵轉(zhuǎn)運(yùn)蛋白1突變斑馬魚骨形態(tài)及骨鈣素變化的初步觀察[A];中華醫(yī)學(xué)會第七次全國骨質(zhì)疏松和骨礦鹽疾病學(xué)術(shù)會議論文匯編[C];2013年
8 林寰東;李小明;馬慧;高鑫;;骨鈣素與肝臟脂肪含量關(guān)系的研究[A];中華醫(yī)學(xué)會第十二次全國內(nèi)分泌學(xué)學(xué)術(shù)會議論文匯編[C];2013年
9 胡雪琴;糜漫天;王繼林;張乾勇;黃國榮;畢桂蘋;袁家林;于斌;;鉛暴露對兒童體內(nèi)鈣及骨鈣素的影響[A];首屆中國西部營養(yǎng)與健康、亞健康學(xué)術(shù)會議論文集[C];2005年
10 陳凌;白潔;;糖尿病微血管病對骨密度及骨鈣素的影響[A];第八屆全國骨質(zhì)疏松年會暨第五屆全國鈣劑年會會議文集[C];2002年
相關(guān)博士學(xué)位論文 前4條
1 楊超;骨鈣素在睪丸間質(zhì)細(xì)胞中表達(dá)及功能研究[D];哈爾濱工業(yè)大學(xué);2014年
2 高t熡,
本文編號:2237991
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2237991.html